Home | Business News | CBJ Newsmakers | ProMIS Neurosciences Adds Pharmaceutical Leader Timothy Rothwell to Board of Advisors ProMIS Neurosciences Adds Pharmaceutical Leader Timothy Rothwell to Board of Advisors CBJ Newsmakers RecommendedMenē Inc. Announces Signing of Asset Purchase AgreementField Trip Announces Closing of Plan of Arrangement and $19.9 Million Private Placement FinancingNioBay Metals confirms mineralization to the north at depth at the James Bay Niobium Project
